Shanghai OPM Biosciences Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	5,605	5,577	4,148	6,332	8,460	-
Market Cap Growth	15.68%	34.44%	-34.49%	-25.16%	-	-
Enterprise Value	4,290	4,263	2,834	4,889	6,795	-
Last Close Price	43.10	49.00	36.14	53.89	71.16	-
PE Ratio	116.49	133.75	197.05	117.18	80.29	-
Forward PE	44.43	55.21	40.23	-	-	-
PS Ratio	15.79	15.71	13.96	26.04	28.74	-
PB Ratio	2.67	2.66	1.98	2.93	3.87	-
P/TBV Ratio	2.71	2.70	2.02	2.99	3.95	-
P/OCF Ratio	-	-	59.91	109.26	75.80	-
EV/Sales Ratio	12.09	12.01	9.53	20.11	23.08	-
EV/EBITDA Ratio	50.26	49.94	67.11	103.93	59.98	-
EV/EBIT Ratio	86.49	85.94	438.58	256.99	76.35	-
Debt / Equity Ratio	0.03	0.03	0.03	0.03	0.04	0.22
Debt / EBITDA Ratio	0.69	0.69	1.25	1.24	0.75	1.45
Debt / FCF Ratio	-	-	-	-	-	14.09
Net Debt / Equity Ratio	-0.62	-0.62	-0.61	-0.65	-0.74	-0.41
Net Debt / EBITDA Ratio	-15.38	-15.38	-30.08	-30.06	-14.34	-3.08
Net Debt / FCF Ratio	-	-	24.61	72.18	45.98	-26.48
Asset Turnover	-	-	0.13	0.11	0.19	0.33
Inventory Turnover	-	-	2.63	2.18	2.76	3.72
Quick Ratio	-	-	12.18	22.37	20.18	4.09
Current Ratio	-	-	12.97	23.49	20.94	4.60
Return on Equity (ROE)	1.99%	1.99%	0.95%	2.45%	7.67%	11.43%
Return on Assets (ROA)	-	-	0.18%	0.51%	3.60%	5.35%
Return on Invested Capital (ROIC)	5.32%	5.20%	0.46%	2.52%	17.58%	17.84%
Return on Capital Employed (ROCE)	-	-	0.30%	0.90%	3.90%	8.50%
Earnings Yield	0.74%	0.75%	0.51%	0.85%	1.24%	-
FCF Yield	-	-	-1.24%	-0.31%	-0.42%	-
Dividend Yield	0.94%	-	1.16%	0.82%	0.60%	-
Payout Ratio	-	-	243.29%	136.63%	1.97%	2.99%
Buyback Yield / Dilution	3.64%	3.64%	-1.72%	-13.48%	-17.43%	-0.20%
Total Shareholder Return	4.58%	3.64%	-0.56%	-12.66%	-16.83%	-0.20%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.